Growth effects of insulin and insulin analogues (Q37503141)

20 August 2017

1 reference

title

Growth effects of insulin and insulin analogues (English)

1 reference

20 August 2017

1 reference

Juergen Sandow

1

1 reference

20 August 2017

1 May 2009

1 reference

Archives of Physiology and Biochemistry

20 August 2017

1 reference

20 August 2017

115

1 reference

20 August 2017

2

1 reference

20 August 2017

72-85

1 reference

Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells

20 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Identification of mammary carcinogens in rodent bioassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Effects of the rapid-acting insulin analog glulisine on cultured human skeletal muscle cells: comparisons with insulin and insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

The process of malignant progression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Role of the time factor in signaling specificity: application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

On the growth rates of human malignant tumors: implications for medical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand-dependent transformed phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin-like growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

21 January 2018

Insulin and colon cancer

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Subcutaneous sarcoma as an index of carcinogenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

IGF and insulin action in the mammary gland: lessons from transgenic and knockout models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

No evidence for accumulation of insulin glargine (LANTUS): a multiple injection study in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin as a growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin-like growth factor-I and cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Mitogenic potential of insulin on lymphoma cells lacking IGF-1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin analogues: impact of cell model characteristics on results and conclusions regarding mitogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin as a potent, specific growth factor in a rat hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin-like growth factor 1 (IGF-1): a growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

The insulin-like growth factor system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

In Vitro Model Systems for the Study of Hormone-Dependent Human Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Biological differences among MCF-7 human breast cancer cell lines from different laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Hormone responsive human breast cancer in long-term tissue culture: effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Diabetes, insulin therapy, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Mammary gland neoplasia in long-term rodent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Role of hormones in mammary cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin as a growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

The role of the IGF system in cancer growth and metastasis: overview and recent insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin glulisine--a comprehensive preclinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Effects of insulin on cellular growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Growth-stimulatory actions of insulin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Function of the IGF-I receptor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Malignant fibrous histiocytoma.An Analysis of 200 Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Signalling through the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Novel insulin analogues and its mitogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

Obesity and cancer: Pathophysiological and biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450902835690

A human cell line from a pleural effusion derived from a breast carcinoma

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/51.5.1409

Identifiers

DOI

10.1080/13813450902835690

1 reference

20 August 2017

1 reference

PubMed ID

19485703